AngioDynamics Inc. has entered into a new Credit Agreement with JPMorgan Chase Bank, N.A. and its subsidiary RITA Medical Systems, LLC. Announced on May 28, 2025, the agreement establishes a $25 million secured revolving credit facility set to mature on May 28, 2027. This facility, guaranteed by RITA and secured by first priority security interests in the assets of the Loan Parties, aims to enhance financial flexibility for AngioDynamics. The company, despite being well-capitalized, views this move as prudent financial management to navigate potential working capital fluctuations, especially during its manufacturing transfer process. The agreement includes customary financial covenants and provisions, with the revolving facility subject to a borrowing base and an initial issuance cap of $2 million for letters of credit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.